PKCzetaII is a target for degradation through the tumour suppressor protein pVHL (Q24299736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

PKCzetaII is a target for degradation through the tumour suppressor protein pVHL (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

Peter Joseph Jacques Parker

27 December 2019

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Xavier Iturrioz

series ordinal

1

0 references

Peter J Parker

series ordinal

2

0 references

language of work or name

English

0 references

publication date

5 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1397-1402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Identification of PKCzetaII: an endogenous inhibitor of cell polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Rat protein kinase c zeta gene contains alternative promoters for generation of dual transcripts with 5'-end heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Molecular recognition in dimerization between PB1 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC Isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

The ubiquitin-proteasome pathway in cell cycle control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

inferred from DOI database lookup

7 January 2021

based on heuristic

The extended protein kinase C superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.02.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.FEBSLET.2007.02.059

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350623%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017